Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released ...
Mar 21, 2017
1
2
(HealthDay)—Targeting of tracked tumor foci allows for improved detection of Gleason score 4 + 3 or greater cancers among men under active surveillance for prostate cancer, according to a study published in the March issue ...
Feb 23, 2017
0
0
The anxiety many men experience after being diagnosed with prostate cancer may lead them to choose potentially unnecessary treatment options, researchers from the University at Buffalo and Roswell Park Cancer Institute report ...
Jan 11, 2017
0
3
(HealthDay)—Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance, according to a study published in the January issue of The Journal of Urology.
Dec 23, 2016
0
0
A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease instead of seeking immediate radiation treatment or surgery.
Oct 20, 2016
0
1
(HealthDay)—For hypogonadal men with prostate cancer, testosterone treatment seems oncologically safe, according to a study published in the October issue of The Journal of Urology.
Sep 16, 2016
0
2
Watch-and-wait approach means some patients could delay taking highly toxic non-curative anticancer drugs that come with substantial side effects
Aug 3, 2016
0
9
Although active surveillance, or watchful waiting, for patients with low risk prostate cancer has become an increasingly acceptable strategy for disease management, many men opt for definitive therapies such as radical prostatectomy ...
Jul 27, 2016
0
3
Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have treatment options: ...
Jul 19, 2016
0
8
(HealthDay)—From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease, according to a research letter published online June 23 in JAMA Oncology.
Jun 29, 2016
1
0
